Tus kws kho mob
QP63-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Empaveli (pegcetacoplan)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 11, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1731 - 1740 ntawm 4204
Tus kws kho mob
QP65-21 Minnesota Health Care Programs Providers use of the Interactive Care Reviewer
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 11, 2021
Tus kws kho mob
P45-21 Behavioral Health Coding for Early Intensive Behavioral Intervention and Applied Behavioral Analysis
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021
Tus kws kho mob
P44-21 Urine Drug Testing Reimbursement Policy
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021
Tus kws kho mob
P48-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021
Tus kws kho mob
P47-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 4, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021
Tus kws kho mob
2021 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021
Tus kws kho mob
P46-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2021